El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
Español (Latinoamérica)
Intuitive Surgical Inc
Abierto
SectorSalud
490.54 0.08
Resumen
Variación precio
24h
Mínimo
480.05
Máximo
491.22
Ingresos | 90M 800M |
|---|---|
Ventas | 361M 2.9B |
P/B Media del Sector | 62.896 66.845 |
Margen de beneficio | 27.894 |
Empleados | 17,021 |
EBITDA | 70M 1.1B |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 meses | +32.11% upside |
Próximas Ganancias | 21 abr 2026 |
|---|
Capitalización de Mercado | -16B 176B |
|---|---|
Apertura anterior | 490.46 |
Cierre anterior | 490.54 |
Noticias sobre sentimiento de mercado
By Acuity
18%
82%
19 / 351 Clasificación en Healthcare
Puntuación técnica
By Trading Central
Confianza
Weak Bearish Evidence
Intuitive Surgical Inc Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Intuitive Surgical Inc Esperado
Precio Objetivo
By TipRanks
32.11% repunte
Estimación a 12 meses
Media 647.56 USD 32.11%
Máximo 750 USD
Mínimo 550 USD
De acuerdo con 19 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Intuitive Surgical Inc Dist en los últimos 3 meses.
Sentimiento
By Acuity
19 / 351 Clasificación en Salud
Noticias sobre sentimiento de mercado
Coyuntura alcista notoria
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por debajo de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Intuitive Surgical Inc
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Live chat